Cargando…
Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
INTRODUCTION: Sex-related differences in clinical manifestations and consequences of Parkinson’s disease (PD) have been poorly explored. Better understanding of sexual dimorphism in neurologic diseases such as PD has been announced as a research priority. The aim of our study was to determine indepe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295791/ https://www.ncbi.nlm.nih.gov/pubmed/28203083 http://dx.doi.org/10.2147/NDT.S124984 |
_version_ | 1782505498864517120 |
---|---|
author | Farhadi, Farzaneh Vosoughi, Kia Shahidi, Gholam Ali Delbari, Ahmad Lökk, Johan Fereshtehnejad, Seyed-Mohammad |
author_facet | Farhadi, Farzaneh Vosoughi, Kia Shahidi, Gholam Ali Delbari, Ahmad Lökk, Johan Fereshtehnejad, Seyed-Mohammad |
author_sort | Farhadi, Farzaneh |
collection | PubMed |
description | INTRODUCTION: Sex-related differences in clinical manifestations and consequences of Parkinson’s disease (PD) have been poorly explored. Better understanding of sexual dimorphism in neurologic diseases such as PD has been announced as a research priority. The aim of our study was to determine independent sex differences in clinical manifestations and subtypes, psychosocial functioning, quality of life (QoL) and its domains between male and female individuals with PD. PATIENTS AND METHODS: A comprehensive list of demographics, motor symptoms and subtypes, nonmotor features, health-related quality of life (HRQoL), psychosocial functioning and general aspects of daily life was assessed in 157 individuals (108 males and 49 females) with idiopathic PD. In order to control for potential confounding variables, we applied Orthogonal Partial Least Squares – Discriminant Analysis (OPLS-DA) to explore the strength of each feature to discriminate male and female patients with PD. RESULTS: While no sex difference was found in the total Unified Parkinson’s Disease Rating Scale (UPDRS) score and cumulative daily dose of levodopa, females had significantly more severe anxiety (mean difference =2.2 [95% confidence interval, CI: 0.5–4.0], P=0.011), worse nutritional status (23.8 [standard deviation, SD =4.2] vs 25.8 [SD =2.6], P=0.003) and poorer QoL (28.3 [SD =15.7] vs 17.9 [SD =14.2], P<0.001). Based on multivariate discriminant analysis, emotional well-being, bodily discomfort, social support, mobility and communication domains of HRQoL, together with anxiety, depression and psychosocial functioning, were the strongest features with more severe/worse status in females after adjustment for potential statistical confounders. CONCLUSION: Our study provides a comprehensive understanding of sexual dimorphism in PD. Anxiety, depression, specific domains of HRQoL (mobility, emotional well-being, social support and bodily discomfort) and psychosocial functioning were significantly worse in female individuals with PD. Sexual dimorphism in PD highlights the features that are more likely to be affected in each sex and should be specifically targeted when managing male and female individuals with PD. |
format | Online Article Text |
id | pubmed-5295791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-52957912017-02-15 Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females Farhadi, Farzaneh Vosoughi, Kia Shahidi, Gholam Ali Delbari, Ahmad Lökk, Johan Fereshtehnejad, Seyed-Mohammad Neuropsychiatr Dis Treat Original Research INTRODUCTION: Sex-related differences in clinical manifestations and consequences of Parkinson’s disease (PD) have been poorly explored. Better understanding of sexual dimorphism in neurologic diseases such as PD has been announced as a research priority. The aim of our study was to determine independent sex differences in clinical manifestations and subtypes, psychosocial functioning, quality of life (QoL) and its domains between male and female individuals with PD. PATIENTS AND METHODS: A comprehensive list of demographics, motor symptoms and subtypes, nonmotor features, health-related quality of life (HRQoL), psychosocial functioning and general aspects of daily life was assessed in 157 individuals (108 males and 49 females) with idiopathic PD. In order to control for potential confounding variables, we applied Orthogonal Partial Least Squares – Discriminant Analysis (OPLS-DA) to explore the strength of each feature to discriminate male and female patients with PD. RESULTS: While no sex difference was found in the total Unified Parkinson’s Disease Rating Scale (UPDRS) score and cumulative daily dose of levodopa, females had significantly more severe anxiety (mean difference =2.2 [95% confidence interval, CI: 0.5–4.0], P=0.011), worse nutritional status (23.8 [standard deviation, SD =4.2] vs 25.8 [SD =2.6], P=0.003) and poorer QoL (28.3 [SD =15.7] vs 17.9 [SD =14.2], P<0.001). Based on multivariate discriminant analysis, emotional well-being, bodily discomfort, social support, mobility and communication domains of HRQoL, together with anxiety, depression and psychosocial functioning, were the strongest features with more severe/worse status in females after adjustment for potential statistical confounders. CONCLUSION: Our study provides a comprehensive understanding of sexual dimorphism in PD. Anxiety, depression, specific domains of HRQoL (mobility, emotional well-being, social support and bodily discomfort) and psychosocial functioning were significantly worse in female individuals with PD. Sexual dimorphism in PD highlights the features that are more likely to be affected in each sex and should be specifically targeted when managing male and female individuals with PD. Dove Medical Press 2017-02-01 /pmc/articles/PMC5295791/ /pubmed/28203083 http://dx.doi.org/10.2147/NDT.S124984 Text en © 2017 Farhadi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Farhadi, Farzaneh Vosoughi, Kia Shahidi, Gholam Ali Delbari, Ahmad Lökk, Johan Fereshtehnejad, Seyed-Mohammad Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
title | Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
title_full | Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
title_fullStr | Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
title_full_unstemmed | Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
title_short | Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
title_sort | sexual dimorphism in parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295791/ https://www.ncbi.nlm.nih.gov/pubmed/28203083 http://dx.doi.org/10.2147/NDT.S124984 |
work_keys_str_mv | AT farhadifarzaneh sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales AT vosoughikia sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales AT shahidigholamali sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales AT delbariahmad sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales AT lokkjohan sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales AT fereshtehnejadseyedmohammad sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales |